166 related articles for article (PubMed ID: 22356766)
1. Translational control of cell fate: from integration of environmental signals to breaching anticancer defense.
Bitterman PB; Polunovsky VA
Cell Cycle; 2012 Mar; 11(6):1097-107. PubMed ID: 22356766
[TBL] [Abstract][Full Text] [Related]
2. Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation.
Bitterman PB; Polunovsky VA
Mol Cancer Ther; 2012 May; 11(5):1051-61. PubMed ID: 22572598
[TBL] [Abstract][Full Text] [Related]
3. Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype.
Issaenko OA; Bitterman PB; Polunovsky VA; Dahlberg PS
Cancer Gene Ther; 2012 Sep; 19(9):609-18. PubMed ID: 22767218
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.
Malka-Mahieu H; Newman M; Désaubry L; Robert C; Vagner S
Clin Cancer Res; 2017 Jan; 23(1):21-25. PubMed ID: 27789529
[TBL] [Abstract][Full Text] [Related]
5. c-Myc and eIF4F constitute a feedforward loop that regulates cell growth: implications for anticancer therapy.
Lin CJ; Malina A; Pelletier J
Cancer Res; 2009 Oct; 69(19):7491-4. PubMed ID: 19773439
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppression by small molecule inhibitors of translation initiation.
Chen L; Aktas BH; Wang Y; He X; Sahoo R; Zhang N; Denoyelle S; Kabha E; Yang H; Freedman RY; Supko JG; Chorev M; Wagner G; Halperin JA
Oncotarget; 2012 Aug; 3(8):869-81. PubMed ID: 22935625
[TBL] [Abstract][Full Text] [Related]
7. Targeting the eIF4F translation initiation complex for cancer therapy.
Konicek BW; Dumstorf CA; Graff JR
Cell Cycle; 2008 Aug; 7(16):2466-71. PubMed ID: 18719377
[TBL] [Abstract][Full Text] [Related]
8. Acquired Tamoxifen Resistance in MCF-7 Breast Cancer Cells Requires Hyperactivation of eIF4F-Mediated Translation.
Fagan DH; Fettig LM; Avdulov S; Beckwith H; Peterson MS; Ho YY; Wang F; Polunovsky VA; Yee D
Horm Cancer; 2017 Aug; 8(4):219-229. PubMed ID: 28577281
[TBL] [Abstract][Full Text] [Related]
9. A Cap for Every Occasion: Alternative eIF4F Complexes.
Ho JJD; Lee S
Trends Biochem Sci; 2016 Oct; 41(10):821-823. PubMed ID: 27283511
[TBL] [Abstract][Full Text] [Related]
10. Developing anti-neoplastic biotherapeutics against eIF4F.
Steinberger J; Chu J; Maïga RI; Sleiman K; Pelletier J
Cell Mol Life Sci; 2017 May; 74(9):1681-1692. PubMed ID: 28004147
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic RNA binding by the eukaryotic initiation factor 4F depends on a minimal RNA length but not on the m7G cap.
Kaye NM; Emmett KJ; Merrick WC; Jankowsky E
J Biol Chem; 2009 Jun; 284(26):17742-50. PubMed ID: 19414591
[TBL] [Abstract][Full Text] [Related]
12. Emerging therapeutics targeting mRNA translation.
Malina A; Mills JR; Pelletier J
Cold Spring Harb Perspect Biol; 2012 Apr; 4(4):a012377. PubMed ID: 22474009
[TBL] [Abstract][Full Text] [Related]
13. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.
Pelletier J; Graff J; Ruggero D; Sonenberg N
Cancer Res; 2015 Jan; 75(2):250-63. PubMed ID: 25593033
[TBL] [Abstract][Full Text] [Related]
14. Translating from cancer to the brain: regulation of protein synthesis by eIF4F.
Kats IR; Klann E
Learn Mem; 2019 Sep; 26(9):332-342. PubMed ID: 31416906
[TBL] [Abstract][Full Text] [Related]
15. m
Coots RA; Liu XM; Mao Y; Dong L; Zhou J; Wan J; Zhang X; Qian SB
Mol Cell; 2017 Nov; 68(3):504-514.e7. PubMed ID: 29107534
[TBL] [Abstract][Full Text] [Related]
16. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
17. La-related protein 1 (LARP1) repression of TOP mRNA translation is mediated through its cap-binding domain and controlled by an adjacent regulatory region.
Philippe L; Vasseur JJ; Debart F; Thoreen CC
Nucleic Acids Res; 2018 Feb; 46(3):1457-1469. PubMed ID: 29244122
[TBL] [Abstract][Full Text] [Related]
18. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation.
Svitkin YV; Herdy B; Costa-Mattioli M; Gingras AC; Raught B; Sonenberg N
Mol Cell Biol; 2005 Dec; 25(23):10556-65. PubMed ID: 16287867
[TBL] [Abstract][Full Text] [Related]
19. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
[TBL] [Abstract][Full Text] [Related]
20. Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells.
Frosi Y; Ramlan SR; Brown CJ
J Vis Exp; 2020 May; (159):. PubMed ID: 32421011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
